Integrative Transcriptomic Signature of tRNA ‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.71892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 04.06.2026. Verfasst von Lei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, RNA, Transfer, Transcriptome, Biomarkers, Tumor. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yangzhou Public Hospitals Reform and High Quality Development Demonstration Project.
Abstract (Originalsprache)
Background
Conventional diagnostic strategies for prostate cancer (PCa) are hindered by suboptimal specificity, frequently resulting in overdiagnosis and unnecessary invasive biopsies. We developed an integrative diagnostic framework based on transcriptomic signatures from tRNA‐derived fragments (tRFs), target genes, and lactylation‐related genes (LRGs), two emerging regulators linked to PCa progression.
Methods
Bulk RNA‐seq data from TCGA‐PCa (499 tumors, 52 normals) and five independent GEO cohorts were analyzed. Differentially expressed genes (DEGs) were identified using edgeR and subsequently assessed for functional enrichment. Candidate markers were obtained by intersecting DEGs with predicted tRFs targets and curated LRGs. A least absolute shrinkage and selection operator (LASSO) model was trained and validated across external cohorts. RT‐qPCR performed clinical confirmation in 30 prostate tissue samples.
Results
Eleven genes overlapped among DEGs, tRF targets, and LRGs, and a seven‐gene diagnostic signature (CSRP1, HMGN4, CALM1, NEFL, MSN, MKI67, ARID3A) was established. The model showed robust performance across all validation datasets, with AUC values of 0.728–0.904, exceeding those of prostate‐specific antigen (PSA) testing. RT‐qPCR supported significant dysregulation of five signature genes in clinical samples, notably decreased NEFL and increased MKI67. Decision curve analysis (DCA) suggested the model could reduce unnecessary biopsies by about 30% at commonly used clinical thresholds.
Conclusion
This integrative model, incorporating tRFs‐associated targets and lactylation‐related signatures, demonstrates superior PCa detection accuracy compared to conventional PSA testing. The seven‐gene signature offers a biologically informed, clinically applicable tool to improve early diagnosis while potentially reducing unnecessary biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
- Department of Oncology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
Förderung
- Yangzhou Public Hospitals Reform and High Quality Development Demonstration Project
Zitieren
APA
Wang, L., Hu, X., Wang, B., Zhang, Y., Yang, J., & Wang, Y. (2026). Integrative Transcriptomic Signature of tRNA ‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71892
Vancouver
Wang L, Hu X, Wang B, Zhang Y, Yang J, Wang Y. Integrative Transcriptomic Signature of tRNA ‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71892
BibTeX
@article{Wang2026,
author = {Wang, Lei and Hu, Xiaoxue and Wang, Bixi and Zhang, Yaping and Yang, Jiajia and Wang, Ying},
title = {Integrative Transcriptomic Signature of tRNA ‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.71892}
}
EUVIMED